Publications

Iskander M, Booy R, Lambert S. The burden of influenza in children. Current Opinion in Infectious Diseases 2007;20:259-63. [Abstract]

Wood N, McIntyre P, Elliott E. Pertussis in infancy: a review of strategies for prevention [invited review] [Portuguese]. . Sociedad Iberoamericana de Informacion Cientifica (SIIC) 2007; May: Online. . [Link]

MacIntyre CR, Burgess M, Isaacs D, McIntyre PB, Menzies R, Hull B. Epidemiology of severe hepatitis A in Indigenous Australian children. Journal of Paediatrics and Child Health 2007;43:383-7. [Abstract]

Ridda I, MacIntyre CR, Lindley RI, McIntyre PB, Sullivan J, Gilbert G, Kovoor P, Manolios N, Fox J. Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines 2007;3:57-60. [Abstract]

Schmitt HJ, Booy R, Aston R, Van Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Weil-Olivier C, Finn A, Olcén P, Fedson D, Peltola H. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Medicine 2007;5:11. [Abstract]

Jelfs J, Macartney K, Cossart Y. Hepatitis B. In: The Cancer Council Australia. National Cancer Prevention Policy 2007–09 . Sydney: The Cancer Council Australia, 2007. [Full text]

Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, McIntyre PB. Sustained measles elimination in Australia and priorities for long term maintenance . Vaccine 2007;25:3574-80. [Abstract]

El Bashir H, Rashid H, Memish ZA, Shafi S, Health at Hajj and Umra Research Group (includes Booy R) . Meningococcal vaccine coverage in Hajj pilgrims [letter] . Lancet 2007;369:1343. [Abstract]

Snelling T, Cripps T, Macartney K, Dalton D, Kesson A, Isaacs D. Nosocomial rotavirus infection in an Australian children’s hospital. Journal of Paediatrics and Child Health 2007;43:327. [Full text]

Heron L, Selnikova O, Moiseieva A, van Damme P, van der Wielen M, Levie K, Hoet B, Stoffel M. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial. Vaccine 2007;25:2817-22. [Abstract]